top of page

Did you catch Ginflex®'s Symposium at the
Singapore Orthopaedic Association (SOA)
46th Annual Scientific Meeting? 

At the recent Singapore Orthopaedic Association (SOA) 2024 Conference, Ginflex® hosted an insightful symposium led by Assoc. Professor Joyce Koh (Senior Consultant, SGH) and Adj. Asst. Professor Barry Tan (Consultant, NUH). The session, entitled "Addressing Unmet Needs in Orthopaedics: Latest Innovations & Clinical Evidence of Ginflex®", focused on the global Arthritis crisis and how Ginflex® fulfils the criteria of an ideal health supplement that slows disease progression as well as manages joint pain & inflammation quickly in just 5 to 7 days!

Click on the video to hear how the symposium went!

Ginflex® Presented as the Ideal Supplement for Arthritis: 

Supported by scientific evidence showing efficacy & safety

Fast onset of action in 5 to 7 days

  • Provides quick relief of pain & inflammation, improves joint function in 5 to 7 days

Established safety profile 

  • Safety parameters i.e. serum, hematology, urine labs evaluated in RCTs remained within normal laboratory range with no adverse effects 

Reduces need for formal analgesia including Paracetamol & NSAIDs

Convenient once daily dosing

Culturally well-accepted & appropriate for diverse patient groups

  • Halal-certified, suitable for Muslims

  • 100% plant-based, suitable for vegetarians & vegans 

Continuous advancements in research with new clinical data 

  • Confidential preview RCT demonstrates continuous improvement in pain, stiffness, physical function & cartilage health even over 6 months

[2024-01-02] Ginflex box R.png
check-mark-3-xxl.png
check-mark-3-xxl.png
check-mark-3-xxl.png
check-mark-3-xxl.png
check-mark-3-xxl.png
check-mark-3-xxl.png
check-mark-3-xxl.png
Screenshot 2024-10-29 183116.png
bottom of page